Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 (HoCoPsy)
Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context
The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.
On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.
By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.
It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.
This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.
Secondary objectives :
- Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
- Assess the lengh of the hospitalization
- Assess the number of patients hospitalized without psychiatric antecedent
- Assess the number of treatment interruptions in the recent history before hospitalization
- Asses the number of patients living alone
- Asses the number of patients using drugs
It is expected to highlight :
- An increase of the number of unvontuntary commitment
- If one or several mental disorders were more at risk of requiring an unvonluntary commitment
- An increased lengh of hospitalization
- An increased number of unvonluntary commitment of patients without psychiatric antecedent
- An increased number of treatment interruptions
- A link between hospitalization and living alone
- A link between hospitalization and using drugs
The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.
The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Montpellier, Francia, 34295
- University Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion criteria:
- Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).
Exclusion criteria:
- refusal to participate
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Unvonluntary commitment from March 12th to April 09th 2019
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019
|
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
|
|
Unvonluntary commitment from March 12th to April 09th 2020
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020
|
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of hospitalized patients
Lasso di tempo: 1 months
|
Number of hospitalized patients From March 12th to April 09th
|
1 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Cause of hospitalization
Lasso di tempo: 1 months
|
Primary psychiatric diagnostic From March 12th to April 09th
|
1 months
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Lengh of hospitalization
Lasso di tempo: 1 months
|
Patients without psychiatric antecedent (number) From March 12th to April 09th
|
1 months
|
|
Treatment interruption
Lasso di tempo: 1 months
|
Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th
|
1 months
|
|
Number of hospitalized patients living alone
Lasso di tempo: 1 months
|
Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th
|
1 months
|
|
Use of drugs
Lasso di tempo: 1 months
|
Number of patients using drugs From March 12th to April 09th
|
1 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Emilie OLIE, MD PhD, University Hospital, Montpellier
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- RECHMPL20_0320
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Disordini mentali
-
Charite University, Berlin, GermanyReclutamentoSchizofrenia Spectrum Disorders (SSD)Germania
-
King's College LondonSouth London and Maudsley NHS Foundation TrustIscrizione su invitoDetenzione in base al Mental Health ActRegno Unito
-
Yonsei UniversityCompletatoInfermieri che lavorano presso il Community Mental Health Welfare CenterCorea, Repubblica di
-
University of Trás-os-Montes and Alto DouroCentro Hospitalar De Trás-Os-Montes E Alto Douro, E.P.E.ReclutamentoDisturbi psicotici | Grave malattia mentale | Schizofrenia Spectrum Disorders (SSD)Portogallo
-
Central Institute of Mental Health, MannheimReclutamentoSchizofrenia Spectrum Disorders (SSD)Germania
-
Tianjin Medical University General HospitalReclutamentoNeuromielite Optica Spectrum Disorders (NMOSD)Cina
-
Tianjin Medical University General HospitalNon ancora reclutamentoNeuromielite ottica (NMO) | Neuromielite Optica Spectrum Disorders (NMOSD)
-
Huashan HospitalNon ancora reclutamentoNeuromielite Optica Spectrum Disorders (NMOSD)Cina
-
Huashan HospitalCompletato
-
Huashan HospitalShanghai AbelZeta Ltd.Non ancora reclutamentoEncefalite autoimmune | Sclerosi multipla (SM) | Sindrome della persona rigida | Neuromielite Optica Spectrum Disorders (NMOSD)